Central Trust Company’s Exelixis EXEL Stock Holding History

Central Trust Company’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$29.4K	Buy	541 +241	+80%	+$11.7K	﹤0.01%	992
2026 Q1	$12.9K	Sell	300 -2	-0.7%	-$86	﹤0.01%	1104
2025 Q4	$13.2K	Buy	302 +2	+0.7%	+$83	﹤0.01%	1074
2025 Q3	$12.4K	Sell	300 -100	-25%	-$4.02K	﹤0.01%	1072
2025 Q2	$17.6K	Sell	400 -50	-11%	-$2K	﹤0.01%	1011
2025 Q1	$16.6K	Sell	450 -100	-18%	-$3.56K	﹤0.01%	1004
2024 Q4	$18.3K	Sell	550 -350	-39%	-$11.4K	﹤0.01%	986
2024 Q3	$23.4K	Hold	900	–	–	﹤0.01%	918
2024 Q2	$20.2K	Sell	900 -338	-27%	-$7.5K	﹤0.01%	931
2024 Q1	$29.4K	Sell	1,238 -460	-27%	-$10.2K	﹤0.01%	906
2023 Q4	$40.7K	Sell	1,698 -62	-4%	-$1.35K	﹤0.01%	830
2023 Q3	$38.5K	Hold	1,760	–	–	﹤0.01%	820
2023 Q2	$33.6K	Buy	+1,760	New	+$33.9K	﹤0.01%	849
2021 Q3	–	Sell	-690	Closed	-$13K	–	1259
2021 Q2	$13K	Sell	690 -4,120	-86%	-$96.1K	﹤0.01%	973
2021 Q1	$109K	Buy	4,810 +3,825	+388%	+$86.4K	﹤0.01%	589
2020 Q4	$20K	Buy	+985	New	+$20.6K	﹤0.01%	801
2019 Q2	–	Sell	-4,180	Closed	-$99K	–	1143
2019 Q1	$99K	Buy	+4,180	New	+$95.3K	0.01%	536

Other funds holding EXEL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Central Trust Company's EXEL Position: Q2 2026 in Review

Central Trust Company increased its Exelixis (EXEL) stake by 80% in Q2 2026, buying an estimated $11.7K and bringing the position to 541 shares worth $29.4K. The position accounts for ﹤0.01% of the portfolio, ranked #992.

Central Trust Company first reported a position in EXEL in Q1 2019 and has held it in 17 quarters since. The position peaked at $109K in Q1 2021. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

Central Trust Company held 541 shares of Exelixis worth $29.4K as of Q2 2026.
Central Trust Company bought 241 Exelixis shares in Q2 2026, an estimated $11.7K.
Exelixis made up ﹤0.01% of Central Trust Company's portfolio in Q2 2026, its #992 holding.
Central Trust Company first reported a position in Exelixis in Q1 2019 and has held it in 17 quarters since.
Central Trust Company's Exelixis position peaked at $109K in Q1 2021.
760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.